Author

Yoona Park

Observed names: Park, Yoona, Y. Park

Institutions: Celltrion (South Korea), LG AI Research (South Korea)

Observed institutions: University of Toronto, Samsung (South Korea), Samsung Medical Center, Vector Institute, Celltrion (South Korea), LG AI Research (South Korea), Samsung Display (South Korea), Sungkyunkwan University

ORCID: 0000-0001-9934-0002

Observed ORCID: 0000-0001-9934-0002

OpenAlex ID: A5033665878

Transformer-Based Models for Question Answering on COVID19

2021 · Ngai, Hillary, Park, Yoona, et al. · arXiv (Cornell University) · 33

Plasma information-based virtual metrology (PI-VM) and mass production process control

2022 · Seolhye Park, Jaegu Seong, et al. · Journal of the Korean Physical Society · 19

Predictive control of the plasma processes in the OLED display mass production referring to the discontinuity qualifying PI-VM

2020 · Seolhye Park, Yongsuk Jang, et al. · Physics of Plasmas · 14

Molecular characterization of colorectal cancer patients and concomitant patient-derived tumor cell establishment

2016 · Haa-Na Song, Chung Lee, et al. · Oncotarget · 14

A randomized, double-blind, Phase 1, single- and multiple-dose placebo-controlled study of the safety and pharmacokinetics of IN-006, an inhaled antibody treatment for COVID-19 in healthy volunteers

2025 · Thomas R. Moench, Lakshmi Botta, et al. · EBioMedicine · 13

Plasma heating characterization of the large area inductively coupled plasma etchers with the plasma information for managing the mass production

2024 · Seolhye Park, Yoona Park, et al. · Physics of Plasmas · 8

Micro-range uniformity control of the etching profile in the OLED display mass production referring to the PI-VM model

2021 · Seolhye Park, Jaegu Seong, et al. · Physics of Plasmas · 7

Data-driven plasma science based plasma etching process design in OLED mass production referring to PI-VM

2024 · Seolhye Park, Jaegu Seong, et al. · Plasma Physics and Controlled Fusion · 6

Detoxifying Language Models with a Toxic Corpus

2022 · Yoona Park, Frank Rudzicz · Workshop on Language Technology for Equality, Diversity, Inclusion (LT-EDI) · 3

WITHDRAWN: 3041eP chatEXAONE Path: A pan-cancer multimodal AI model achieves expert-validated performance in pathology-based clinical question answering

2025 · J.K. Myung, J. Kim, et al. · Annals of Oncology

Author response for "Stable nebulization and muco‐trapping properties of regdanvimab/ IN ‐006 support its development as a potent, dose‐saving inhaled therapy for COVID ‐19"

2022 · Morgan D. McSweeney, Ian Stewart, et al. · Publons reviews and discussion

Works count: 11

Citation count: 117

H-index: 7

I10-index: 5